BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35910022)

  • 1. MLP-Based Regression Prediction Model For Compound Bioactivity.
    Qin Y; Li C; Shi X; Wang W
    Front Bioeng Biotechnol; 2022; 10():946329. PubMed ID: 35910022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A machine learning-based approach to ERĪ± bioactivity and drug ADMET prediction.
    An T; Chen Y; Chen Y; Ma L; Wang J; Zhao J
    Front Genet; 2022; 13():1087273. PubMed ID: 36685926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and Screening Model for Products Based on Fusion Regression and XGBoost Classification.
    Wu J; Kong L; Yi M; Chen Q; Cheng Z; Zuo H; Yang Y
    Comput Intell Neurosci; 2022; 2022():4987639. PubMed ID: 35958779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization Modeling of Anti - breast Cancer Candidate Drugs.
    Zhou S; Li Y; Zhang X
    Biotechnol Genet Eng Rev; 2023 Mar; ():1-19. PubMed ID: 36960749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two-stage modeling approach for breast cancer survivability prediction.
    Sedighi-Maman Z; Mondello A
    Int J Med Inform; 2021 May; 149():104438. PubMed ID: 33730681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and qualitative prediction of corneal permeability for drug-like compounds.
    Ghorbanzad'e M; Fatemi MH; Karimpour M; Andersson PL
    Talanta; 2011 Oct; 85(5):2686-94. PubMed ID: 21962703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting quality of life after breast cancer surgery using ANN-based models: performance comparison with MR.
    Tsai JT; Hou MF; Chen YM; Wan TT; Kao HY; Shi HY
    Support Care Cancer; 2013 May; 21(5):1341-50. PubMed ID: 23203653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting drug-target interaction network using deep learning model.
    You J; McLeod RD; Hu P
    Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Modeling of Estrogen Receptor Binding Agents Using Advanced Cheminformatics Tools and Massive Public Data.
    Ribay K; Kim MT; Wang W; Pinolini D; Zhu H
    Front Environ Sci; 2016 Mar; 4():. PubMed ID: 27642585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive respiratory signal prediction using dual multi-layer perceptron neural networks.
    Sun W; Wei Q; Ren L; Dang J; Yin FF
    Phys Med Biol; 2020 Sep; 65(18):185005. PubMed ID: 32924976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Modeling of Anti-Breast Cancer Candidate Drugs Based on Graph Model Feature Selection.
    Chen R; He Z; Huang S; Shen L; Zhou X
    Comput Math Methods Med; 2022; 2022():8418048. PubMed ID: 36081436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance comparison between Logistic regression, decision trees, and multilayer perceptron in predicting peripheral neuropathy in type 2 diabetes mellitus.
    Li CP; Zhi XY; Ma J; Cui Z; Zhu ZL; Zhang C; Hu LP
    Chin Med J (Engl); 2012 Mar; 125(5):851-7. PubMed ID: 22490586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
    Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
    Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Artificial Neural Networks to Predict the Physicochemical Characteristics of Water Quality in Three District Municipalities, Eastern Cape Province, South Africa.
    Setshedi KJ; Mutingwende N; Ngqwala NP
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34069195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Tumor Shrinkage Pattern to Neoadjuvant Chemotherapy Using a Multiparametric MRI-Based Machine Learning Model in Patients With Breast Cancer.
    Huang Y; Chen W; Zhang X; He S; Shao N; Shi H; Lin Z; Wu X; Li T; Lin H; Lin Y
    Front Bioeng Biotechnol; 2021; 9():662749. PubMed ID: 34295877
    [No Abstract]   [Full Text] [Related]  

  • 16. A New Method on Kerma Estimation in Mammography Screenings.
    Nabipour M; Deevband MR; Asgharzadeh Alvar A; Soleimani N; Sadeghi S
    J Biomed Phys Eng; 2021 Oct; 11(5):595-602. PubMed ID: 34722404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory signal prediction based on adaptive boosting and multi-layer perceptron neural network.
    Sun WZ; Jiang MY; Ren L; Dang J; You T; Yin FF
    Phys Med Biol; 2017 Aug; 62(17):6822-6835. PubMed ID: 28665297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
    Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
    Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical decision support system for prediction of pregnancy outcome in pregnant women with systemic lupus erythematosus.
    Paydar K; Niakan Kalhori SR; Akbarian M; Sheikhtaheri A
    Int J Med Inform; 2017 Jan; 97():239-246. PubMed ID: 27919382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New consensus multivariate models based on PLS and ANN studies of sigma-1 receptor antagonists.
    Oliveira AA; Lipinski CF; Pereira EB; Honorio KM; Oliveira PR; Weber KC; Romero RAF; de Sousa AG; da Silva ABF
    J Mol Model; 2017 Oct; 23(10):302. PubMed ID: 28971260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.